Therapeutic efficacy of environmental enrichment on behavioral, endocrine, and synaptic alterations in an animal model of maternal immune activation.

Amygdala Corticosterone Environmental enrichment Experience Fetal programming Glucocorticoid receptor Inflammation Maternal immune activation Memory Sex difference Social Housing Synaptic plasticity

Journal

Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 6 5 2020
Statut: ppublish

Résumé

Maternal immune activation (MIA) has been identified as a significant risk factor for several neurodevelopmental disorders. We have previously demonstrated that postpubertal environmental enrichment (EE) rescues and promotes resiliency against MIA in male rats. Importantly, EE protocols have demonstrated clinical relevancy in human rehabilitation settings. Applying some of the elements of these EE protocols (e.g. social, physical, cognitive stimulation) to animal models of health and disease allows for the exploration of the mechanisms that underlie their success. Here, using a MIA model, we further investigate the rehabilitative potential of complex environments with a focus on female animals. Additionally, we expand upon some of our previous work by exploring genetic markers of synaptic plasticity and stress throughout several brain regions of both sexes. In the current study, standard housed female Sprague-Dawley rats were challenged with either the inflammatory endotoxin lipopolysaccharide (LPS; 100 μg/kg) or saline (equivolume) on gestational day 15. On postnatal day 50, male and female offspring were randomized into one of three conditions that differed in terms of cage size, number of cage mates (social stimulation) and enrichment materials. Spatial discrimination ability and social behavior were assessed six weeks later. Similar to our previously published work in males, our results revealed that a single LPS injection during mid gestation disrupted spatial discrimination ability in female rats. Postpubertal EE rescued this disruption. On the endocrine level, EE dampened elevations in plasma corticosterone that followed MIA, which may mediate EE's rehabilitative effects in female offspring. Within the prefrontal cortex, hippocampus, amygdala, and hypothalamus, MIA and EE altered the mRNA expression of several genes associated with resiliency and synaptic plasticity in both sexes. Overall, our findings provide further evidence that EE may serve as a therapeutic intervention for MIA-induced behavioral and cognitive deficits. Moreover, we identify some sexually dimorphic molecular mechanisms that may underlie these impairments and their rescue.

Identifiants

pubmed: 32368757
doi: 10.1016/j.bbih.2020.100043
pmc: PMC7197879
mid: NIHMS1572273
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIMH NIH HHS
ID : R15 MH114035
Pays : United States

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Références

Dev Neurobiol. 2010 Apr;70(5):304-22
pubmed: 20186705
Psychoneuroendocrinology. 2015 Feb;52:153-67
pubmed: 25437120
J Neurosci. 2018 Mar 28;38(13):3358-3372
pubmed: 29491010
Prog Neurobiol. 2010 Mar;90(3):285-326
pubmed: 19857543
Schizophr Bull. 2009 May;35(3):631-7
pubmed: 18832344
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S186-95
pubmed: 19560279
J Autism Dev Disord. 2001 Dec;31(6):545-9
pubmed: 11814264
Dev Psychobiol. 2018 Nov;60(7):805-813
pubmed: 29943435
Brain Behav Immun. 2011 Oct;25(7):1384-92
pubmed: 21521653
Ann N Y Acad Sci. 2015 Mar;1338:38-57
pubmed: 25315318
Pharmacol Ther. 2015 May;149:213-26
pubmed: 25562580
Nat Rev Neurosci. 2007 Feb;8(2):101-13
pubmed: 17237803
J Neuroinflammation. 2017 Nov 2;14(1):212
pubmed: 29096641
Physiol Behav. 1995 Dec;58(6):1085-9
pubmed: 8623006
Brain Behav Immun. 2016 Oct;57:151-160
pubmed: 27002704
Neuropsychopharmacology. 2003 Oct;28(10):1778-89
pubmed: 12865897
J Psychiatry Neurosci. 2004 Jul;29(4):282-6
pubmed: 15309044
Behav Neurosci. 2015 Aug;129(4):412-22
pubmed: 26052790
Physiol Behav. 1998 Jun 1;64(3):303-10
pubmed: 9748097
Pharmacol Biochem Behav. 2002 Aug;73(1):209-24
pubmed: 12076740
Neurochem Int. 2007 Nov-Dec;51(6-7):333-55
pubmed: 17517448
Neurosignals. 2010;18(2):113-28
pubmed: 20924155
Science. 1982 Apr 9;216(4542):193-6
pubmed: 6121377
Asian J Psychiatr. 2013 Feb;6(1):22-8
pubmed: 23380313
Disabil Rehabil. 2014;36(3):255-62
pubmed: 23627534
PLoS One. 2014 Aug 11;9(8):e104433
pubmed: 25111339
Physiol Behav. 2017 May 1;173:144-155
pubmed: 28167147
Transl Psychiatry. 2019 Feb 14;9(1):90
pubmed: 30765690
Anim Behav. 2000 Apr;59(4):677-688
pubmed: 10792923
Neuroimmunomodulation. 2014;21(1):37-44
pubmed: 24216750
J Physiol. 2005 Aug 1;566(Pt 3):967-77
pubmed: 15932885
Am J Psychiatry. 2006 May;163(5):927-9
pubmed: 16648337
Neuropsychologia. 2010 Jul;48(8):2303-15
pubmed: 20350557
Neuroimmunomodulation. 2010;17(4):240-51
pubmed: 20203530
Neurobiol Learn Mem. 1995 Jul;64(1):49-57
pubmed: 7582812
J Neurosci. 2007 Oct 3;27(40):10695-702
pubmed: 17913903
Biol Sex Differ. 2012 Jun 14;3(1):15
pubmed: 22697211
Science. 2010 Mar 26;327(5973):1571-2
pubmed: 20339045
Behav Brain Res. 2008 Feb 11;187(1):41-7
pubmed: 17904657
J Neurosci. 2008 Mar 12;28(11):2837-44
pubmed: 18337414
Am J Physiol Regul Integr Comp Physiol. 2004 Jun;286(6):R1024-9
pubmed: 14988088
Psychoneuroendocrinology. 2000 Apr;25(3):213-38
pubmed: 10737694
Nat Neurosci. 2005 Mar;8(3):270-2
pubmed: 15723058
J Neurosci. 2007 Mar 14;27(11):2948-57
pubmed: 17360918
J Clin Invest. 1994 Jun;93(6):2600-7
pubmed: 8200998
J Physiol. 2003 Feb 1;546(Pt 3):859-67
pubmed: 12563010
Ann N Y Acad Sci. 2004 Jun;1018:281-7
pubmed: 15240379
Dev Psychobiol. 2006 Mar;48(2):162-8
pubmed: 16489598
Curr Pharm Des. 2014;20(31):5104-14
pubmed: 24345269
Nat Rev Neurosci. 2000 Dec;1(3):191-8
pubmed: 11257907
Physiol Behav. 1994 Nov;56(5):1041-8
pubmed: 7824569
Brain Behav Immun. 2010 Aug;24(6):881-97
pubmed: 20230889
J Neuroendocrinol. 2004 May;16(5):423-31
pubmed: 15117335
J Comp Psychol. 1993 Jun;107(2):216-22
pubmed: 8370276
J Neurosci Res. 2012 Oct;90(10):1903-12
pubmed: 22714803
Int Rev Neurobiol. 2004;59:47-72
pubmed: 15006484
Horm Behav. 2012 Aug;62(3):228-36
pubmed: 22516179
Biol Psychiatry. 2011 Nov 1;70(9):842-51
pubmed: 21816387
Brain Behav Immun. 2017 Jul;63:50-59
pubmed: 27940258
Nat Rev Neurol. 2014 Nov;10(11):643-60
pubmed: 25311587
Neuroscience. 2018 Jan 15;369:399-411
pubmed: 29183827
Anat Embryol (Berl). 2006 Jan;211(1):61-9
pubmed: 16374610
Eur J Neurosci. 2006 May;23(10):2749-59
pubmed: 16817878
J Neurosci. 2011 Jul 20;31(29):10721-31
pubmed: 21775615
Brain Behav Immun. 2020 Jan;83:44-55
pubmed: 31493445
Science. 2016 Aug 19;353(6301):772-7
pubmed: 27540164
J Comp Neurol. 2011 Dec 15;519(18):3599-639
pubmed: 21800319
Eur J Pharmacol. 2011 Jan 15;650(2-3):586-95
pubmed: 21034739
Neuropsychopharmacology. 2019 Jan;44(2):245-258
pubmed: 30188509
J Neurosci. 2005 Apr 27;25(17):4243-51
pubmed: 15858050
Arch Gen Psychiatry. 2003 Jun;60(6):565-71
pubmed: 12796219
J Neurosci. 1997 Mar 1;17(5):1838-47
pubmed: 9030642
Brain Behav Immun. 2015 Nov;50:249-258
pubmed: 26218293
Neuroscience. 2015 Jul 9;298:455-66
pubmed: 25934038
Brain Behav Immun. 2012 May;26(4):623-34
pubmed: 22310921
Biol Psychiatry. 2006 Mar 15;59(6):546-54
pubmed: 16256957
J Comp Neurol. 2006 Dec 20;499(6):924-32
pubmed: 17072842
Pediatr Res. 2000 Jan;47(1):64-72
pubmed: 10625084
Neuroscience. 1999;94(1):279-86
pubmed: 10613518
Acta Histochem. 2004;106(3):199-205
pubmed: 15186927
Psychiatry Res. 2004 Mar 15;125(3):247-55
pubmed: 15051185
Int J Dev Neurosci. 2011 Oct;29(6):663-71
pubmed: 21382466
Neuroscience. 2010 Mar 31;166(3):763-70
pubmed: 20074621
Schizophr Bull. 1990;16(2):211-27
pubmed: 2197714
PLoS One. 2013 Dec 02;8(12):e82244
pubmed: 24312647
Neurosci Lett. 1992 Apr 13;138(1):153-6
pubmed: 1407655
Neuroscience. 2012 Sep 18;220:267-76
pubmed: 22710068
BMC Neurol. 2014 Oct 07;14:203
pubmed: 25287779
FASEB J. 2003 May;17(8):911-3
pubmed: 12626441
Horm Behav. 2003 Feb;43(2):281-92
pubmed: 12694638
Dev Neurobiol. 2012 Oct;72(10):1335-48
pubmed: 22730147
Neurosci Biobehav Rev. 1998 Mar;22(2):143-59
pubmed: 9579307
Neurosci Biobehav Rev. 2011 Jan;35(3):565-72
pubmed: 20620164
Trends Mol Med. 2011 Jul;17(7):389-94
pubmed: 21482187
Physiol Behav. 2001 Jul;73(4):649-58
pubmed: 11495671
Brain Behav Immun. 2016 Jul;55:25-38
pubmed: 26408796
Clin Rehabil. 2017 Nov;31(11):1516-1528
pubmed: 28459184
J Psychopharmacol. 2015 Feb;29(2):97-115
pubmed: 25586400
Neuroscience. 2009 Dec 1;164(2):788-97
pubmed: 19723563
Curr Opin Neurol. 2015 Apr;28(2):91-102
pubmed: 25695134
Neuropsychopharmacology. 2017 Jun;42(7):1435-1446
pubmed: 28102228
Neuroscience. 2012 Jan 10;201:184-98
pubmed: 22119062
Front Behav Neurosci. 2009 Sep 15;3:25
pubmed: 19826497
Brain Behav Immun. 2014 Nov;42:178-90
pubmed: 25011058
FASEB J. 2007 Jul;21(9):2033-41
pubmed: 17351125
Neuropharmacology. 2014 Jan;76 Pt C:639-56
pubmed: 23602987

Auteurs

Xin Zhao (X)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Alejandro N Rondón-Ortiz (AN)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Erika P Lima (EP)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Madeline Puracchio (M)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Ryland C Roderick (RC)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Amanda C Kentner (AC)

School of Arts & Sciences, Health Psychology Program, Massachusetts College of Pharmacy and Health Sciences, Boston Massachusetts, United States 02115.

Classifications MeSH